great minds. brilliant research.
Our team is a diverse group of innovators at the cutting edge of science.
how 12-15 came to be
Dr. Saion Sinha has been leading cutting edge research into difficult scientific problems since he was a student studying physics at the Indian Institute of Technology in Kharagpur, India. He received his PhD from the University of Kentucky and serves as a professor and researcher at the University of New Haven.
After developing tests for Lyme disease and pioneering a patent for the use of carbon nanowire in testing DNA, Dr. Sinha founded 12-15 Molecular Diagnostics in 2016. The organization has studied a range of airborne disease and viruses in animals.
In 2018, the 12-15 team developed the advanced technique of Hybridization, which uses carbon-based nanomaterial to process biofluids electronically. Using this technology, the 12-15 team has developed Veralize, a device that enables a 20 minute saliva test for COVID-19 with 95% sensitivity and accuracy. Veralize is currently applying for FDA approval and expects to have a product on the market by the fourth quarter of 2020.
“
There is a serious need for rapid testing right now. We will continue improving our devices. Our goal is to keep making a difference in people's lives.
